Free Trial

Pro-Dex (PDEX) News Today

Pro-Dex logo
$42.95 -0.31 (-0.72%)
Closing price 01/30/2025 04:00 PM Eastern
Extended Trading
$45.40 +2.46 (+5.72%)
As of 01/30/2025 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Pro-Dex, Inc. stock logo
Pro-Dex (NASDAQ:PDEX) Issues Earnings Results, Beats Estimates By $0.23 EPS
Pro-Dex (NASDAQ:PDEX - Get Free Report) posted its quarterly earnings data on Thursday. The medical instruments supplier reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.23. Pro-Dex had a net margin of 9.17% and a return on equity of 16.74%.
Pro-Dex, Inc. stock logo
Raymond E. Cabillot Sells 5,381 Shares of Pro-Dex, Inc. (NASDAQ:PDEX) Stock
Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 5,381 shares of the firm's stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $41.64, for a total value of $224,064.84. Following the sale, the director now directly owns 319,752 shares in the company, valued at $13,314,473.28. This trade represents a 1.66 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Pro-Dex, Inc. stock logo
Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 835 Shares
Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 835 shares of the firm's stock in a transaction dated Thursday, January 23rd. The stock was sold at an average price of $42.00, for a total transaction of $35,070.00. Following the completion of the transaction, the director now owns 334,646 shares of the company's stock, valued at approximately $14,055,132. The trade was a 0.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Pro-Dex, Inc. stock logo
Insider Selling: Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells 6,931 Shares of Stock
Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 6,931 shares of the stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $45.22, for a total value of $313,419.82. Following the completion of the transaction, the director now owns 337,752 shares of the company's stock, valued at $15,273,145.44. The trade was a 2.01 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Pro-Dex, Inc. stock logo
12,233 Shares in Pro-Dex, Inc. (NASDAQ:PDEX) Acquired by Ritholtz Wealth Management
Ritholtz Wealth Management bought a new position in Pro-Dex, Inc. (NASDAQ:PDEX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 12,233 shares of the medical instruments supplier's stock, v
Pro-Dex, Inc. stock logo
Raymond E. Cabillot Sells 6,820 Shares of Pro-Dex, Inc. (NASDAQ:PDEX) Stock
Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 6,820 shares of the business's stock in a transaction dated Friday, January 17th. The shares were sold at an average price of $44.86, for a total value of $305,945.20. Following the sale, the director now directly owns 344,683 shares of the company's stock, valued at approximately $15,462,479.38. This trade represents a 1.94 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Pro-Dex, Inc. stock logo
Pro-Dex, Inc. (NASDAQ:PDEX) Short Interest Update
Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) was the target of a large decline in short interest during the month of December. As of December 31st, there was short interest totalling 20,000 shares, a decline of 25.1% from the December 15th total of 26,700 shares. Currently, 1.0% of the shares of the company are short sold. Based on an average daily volume of 35,400 shares, the short-interest ratio is currently 0.6 days.
Pro-Dex, Inc. stock logo
Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 1,200 Shares
Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 1,200 shares of Pro-Dex stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $47.76, for a total value of $57,312.00. Following the transaction, the director now directly owns 359,646 shares of the company's stock, valued at $17,176,692.96. The trade was a 0.33 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Pro-Dex, Inc. stock logo
Insider Selling: Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells 3,624 Shares of Stock
Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) Director Raymond E. Cabillot sold 3,624 shares of the firm's stock in a transaction on Monday, January 13th. The stock was sold at an average price of $46.66, for a total value of $169,095.84. Following the completion of the transaction, the director now owns 356,022 shares in the company, valued at approximately $16,611,986.52. This trade represents a 1.01 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Returns On Capital At Pro-Dex (NASDAQ:PDEX) Have Stalled
Pro-Dex, Inc. stock logo
StockNews.com Upgrades Pro-Dex (NASDAQ:PDEX) to Strong-Buy
StockNews.com upgraded Pro-Dex from a "buy" rating to a "strong-buy" rating in a research report on Saturday.
Pro-Dex, Inc. stock logo
StockNews.com Downgrades Pro-Dex (NASDAQ:PDEX) to Buy
StockNews.com cut shares of Pro-Dex from a "strong-buy" rating to a "buy" rating in a research note on Friday.
Pro-Dex shareholders elect board, ratify accounting firm
Pro-Dex, Inc. stock logo
Pro-Dex (NASDAQ:PDEX) Given New $52.00 Price Target at Ascendiant Capital Markets
Ascendiant Capital Markets boosted their price objective on Pro-Dex from $30.00 to $52.00 and gave the stock a "buy" rating in a research note on Monday.
Pro-Dex, Inc. (NASDAQ:PDEX) CFO Sells $40,020.00 in Stock
Pro-Dex, Inc. stock logo
Insider Selling: Pro-Dex, Inc. (NASDAQ:PDEX) CFO Sells 1,000 Shares of Stock
Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) CFO Alisha Charlton sold 1,000 shares of the business's stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $40.02, for a total transaction of $40,020.00. Following the completion of the sale, the chief financial officer now directly owns 15,339 shares of the company's stock, valued at approximately $613,866.78. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.
Pro-Dex, Inc. Reports Strong Quarterly Earnings Growth
Pro-Dex reports Q1 EPS 75c, one estimate 29c
Pro-Dex Shares Rise 45% as It Swings to 1Q Profit
Pro-Dex, Inc. stock logo
Pro-Dex (NASDAQ:PDEX) Stock Price Passes Above 200-Day Moving Average - Should You Sell?
Pro-Dex (NASDAQ:PDEX) Stock Price Passes Above 200 Day Moving Average - Should You Sell?
Pro-Dex, Inc. stock logo
Pro-Dex (NASDAQ:PDEX) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What Happened
Pro-Dex (NASDAQ:PDEX) Shares Cross Above Two Hundred Day Moving Average - Should You Sell?
Pro-Dex Inc (PDEX) Stock Price Up 3.99% on Oct 2
Pro-Dex, Inc. stock logo
Pro-Dex (NASDAQ:PDEX) PT Raised to $30.00 at Ascendiant Capital Markets
Ascendiant Capital Markets boosted their price target on shares of Pro-Dex from $28.00 to $30.00 and gave the company a "buy" rating in a report on Monday.
Pro-Dex, Inc. stock logo
Pro-Dex (NASDAQ:PDEX) Upgraded to Strong-Buy by StockNews.com
StockNews.com upgraded Pro-Dex from a "buy" rating to a "strong-buy" rating in a research note on Saturday.
Pro-Dex, Inc. stock logo
Pro-Dex (NASDAQ:PDEX) Releases Quarterly Earnings Results, Beats Estimates By $0.11 EPS
Pro-Dex (NASDAQ:PDEX - Get Free Report) announced its quarterly earnings data on Thursday. The medical instruments supplier reported $0.46 earnings per share for the quarter, beating analysts' consensus estimates of $0.35 by $0.11. Pro-Dex had a return on equity of 6.50% and a net margin of 4.13%.
Pro-Dex, Inc. stock logo
Pro-Dex (NASDAQ:PDEX) Downgraded by StockNews.com
StockNews.com cut shares of Pro-Dex from a "strong-buy" rating to a "buy" rating in a research note on Friday.
Pro-Dex, Inc. stock logo
Pro-Dex (NASDAQ:PDEX) Stock Price Passes Above 200 Day Moving Average of $18.59
Pro-Dex (NASDAQ:PDEX) Shares Pass Above 200-Day Moving Average of $18.59
Pro-Dex, Inc. stock logo
Pro-Dex, Inc. (NASDAQ:PDEX) Short Interest Down 18.9% in July
Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) was the recipient of a large drop in short interest in the month of July. As of July 31st, there was short interest totalling 9,000 shares, a drop of 18.9% from the July 15th total of 11,100 shares. Currently, 0.4% of the shares of the company are sold short. Based on an average trading volume of 6,900 shares, the days-to-cover ratio is currently 1.3 days.
Pro-Dex, Inc. stock logo
Pro-Dex (NASDAQ:PDEX) Shares Pass Above Two Hundred Day Moving Average of $18.65
Pro-Dex (NASDAQ:PDEX) Share Price Crosses Above 200 Day Moving Average of $18.65
Pro-Dex, Inc. stock logo
Pro-Dex (NASDAQ:PDEX) Stock Price Passes Above Two Hundred Day Moving Average of $18.75
Pro-Dex (NASDAQ:PDEX) Stock Price Crosses Above 200 Day Moving Average of $18.75
CB Aug 2024 285.000 call
Pro-Dex, Inc. (PDXN.F)
Pro-Dex, Inc. stock logo
Pro-Dex (NASDAQ:PDEX) Share Price Crosses Above Two Hundred Day Moving Average of $18.79
Pro-Dex (NASDAQ:PDEX) Shares Pass Above 200 Day Moving Average of $18.79
Get Pro-Dex News Delivered to You Automatically

Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter.

PDEX Media Mentions By Week

PDEX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PDEX
News Sentiment

0.96

0.72

Average
Medical
News Sentiment

PDEX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PDEX Articles
This Week

10

1

PDEX Articles
Average Week

Get Pro-Dex News Delivered to You Automatically

Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:PDEX) was last updated on 1/31/2025 by MarketBeat.com Staff
From Our Partners